Scientific work

Prof. Dr. Meral Beksaç

911 publications. The source of the information is stated next to each publication.

Back to profile

  1. The impact of disparity in short tandem repeats (STRS) analysis on the outcome of allogeneic hematopoietic cell transplantation (allo-HCT) from HLA-identical sibling donors

    Haematologica, 2007

    Source: ORCID

  2. The impact of disparity in short tandem repeats analysis on the outcome of allogeneic haematopoietic cell transplantation from HLA-identical sibling donors

    Bone Marrow Transplantation, 2007

    Source: ORCID

  3. The impact of pretransplant imatinib use in allogeneic haematopoietic cell transplantation for CML:: a single-centre comparative analysis

    Bone Marrow Transplantation, 2007

    Source: ORCID

  4. Time intervals preceeding autologous stem cell transplantation in multiple myeloma patients: a single-centre intent to transplant analysis

    Bone Marrow Transplantation, 2007

    Source: ORCID

  5. Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI

    Haematologica, 2007

    Source: ORCID

  6. Treatment of relapse after allogeneic stem cell transplantation in CML patients: imatinib only versus imatinib&DLI

    Bone Marrow Transplantation, 2007

    Source: ORCID

  7. HLA Typing with Sequence-Specific Oligonucleotide Primed PCR (PCR-SSO)and Use of the Luminex™ Technology

    Humana Press eBooks, 2007

    DOI 10.1385/1-59745-223-8:61 Source: OpenAlex

  8. Sequence-Specific Primed PCR (PCR-SSP) Typing of HLA Class I and Class II Alleles

    Humana Press eBooks, 2007

    DOI 10.1385/1-59745-223-8:51 Source: OpenAlex

  9. Identification of Bone Marrow Derived Nonhematopoietic Cells by Double Labeling with Immunohistochemistry and In Situ Hybridization

    Humana Press eBooks, 2007

    DOI 10.1385/1-59745-223-8:145 Source: OpenAlex

  10. Class I and II antigens that are associated with rate or age at presentation of multiple myeloma: Preliminary results from two centers in Turkey

    Tissue Antigens, 2006

    Source: ORCID

  11. Comparison of hybrid capture and reverse transcriptase polymerase chain reaction methods in terms of diagnosing human cytomegalovirus infection in patients following hematopoietic stem cell transplantation

    Saudi Medical Journal, 2006

    Source: ORCID

  12. Cytomegalovirus antigenemia is observed more frequently following allogeneic peripheral blood stem cell transplantation compared to bone marrow transplantation

    Turkish Journal of Hematology, 2006

    PMID 27265292 1 citation (OpenAlex) Source: ORCID

  13. Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest?

    Transfusion and Apheresis Science, 2006

    DOI 10.1016/j.transci.2005.12.006 PMID 16545614 1 citation (Europe PMC) Source: ORCID

  14. Evaluation of the effect of transplant-related factors and tissue injury on donor-derived hepatocyte and gastrointestinal epithelial cell repopulation following hematopoietic cell transplantation

    Bone Marrow Transplantation, 2006

    DOI 10.1038/sj.bmt.1705214 PMID 16299546 3 citations (Europe PMC) Open-access full textSource: ORCID

  15. HLA B51-DR04 phenotype which is an infrequent observation in multiple myeloma may be associated with longer disease-free survival: preliminary results from two centres in Turkey

    Bone Marrow Transplantation, 2006

    Source: ORCID

  16. High dose (HD-AraC) vs standard dose cytosine arabinoside (SD-AraC) during induction in acute myelogenous leukemia (AML): Impact on stem cell mobilization after consolidation and on autologous transplantation (Second report of the EORTC-leukemia group (LG) - GIMEMA AML12 trial

    Blood, 2006

    Source: ORCID

  17. International uniform response criteria for multiple myeloma

    Leukemia, 2006

    DOI 10.1038/sj.leu.2404284 PMID 16855634 2,130 citations (Europe PMC) Source: ORCID

  18. Killer Ig-like receptor (KIR) incompatibility has an impact on acute graft-versus-host disease incidence, overall and disease-free survival in related allogeneic transplants for leukaemia

    Bone Marrow Transplantation, 2006

    Source: ORCID

  19. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma

    Haematologica, 2006

    Source: ORCID

  20. Pyrimidine 5' nucleotidase-1 (P5N-1) deficiency associated with 4 novel mutations in 5 new Turkish families: Genotype-phenotype analysis

    Blood, 2006

    DOI 10.1182/blood.v108.11.3743.3743 1 citation (OpenAlex) Source: ORCID

  21. Retrospective validation of an apheresis cycle calculator on autologous PBSC collection in myeloma and malignant lymphoma patients

    Cytotherapy, 2006

    Source: ORCID

  22. Risk adapted stem cell transplantation?

    Annals of Hematology, 2006

    Source: ORCID

  23. Role of killer inhibitory receptor (KIR) allele and ligand mismatches (mm) in HLA identical sibling haematopoetic stem cell transplants

    Tissue Antigens, 2006

    Source: ORCID

  24. Two independent effects of immunoglobulin-like receptor (KIR) allele matching between siblings: Inhibitory KIR (iKIR) mismatches are associated with graft versus host disease (GVHD) while activatory KIR matches (aKIR) and cGVHD are associated with graft versus leukemia (GVL)

    Blood, 2006

    DOI 10.1182/blood.v108.11.2912.2912 1 citation (OpenAlex) Source: ORCID

  25. bcr,abl fusion binding HLA molecule frequencies among patients with CML

    Human Immunology, 2006

    DOI 10.1016/j.humimm.2006.08.261 Source: ORCID

  26. High Dose (HD-AraC) vs Standard Dose Cytosine Arabinoside (SD-AraC) during Induction in Acute Myelogenous Leukemia (AML): Impact on Stem Cell Mobilization after Consolidation and on Autologous Transplantation (Second Report of the EORTC-Leukemia Group (LG) - GIMEMA AML-12 Trial.

    Blood, 2006

    DOI 10.1182/blood.v108.11.609.609 1 citation (OpenAlex) Source: OpenAlex

  27. AF-1 Cervical Cancer Screening in Turkey(Cervical Cancer Screening in Asian Countries)

    日本臨床細胞学会雑誌, 2006

    Open-access full textSource: OpenAlex

  28. An automated differential blood count system

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 2005

    DOI 10.1109/iembs.2001.1017309 79 citations (OpenAlex) Open-access full textSource: OpenAlex

  29. A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 (pCD34) count at recovery following remission induction (RI) therapy (Supp. by Ankara university2003-0809114)

    Blood, 2005

    DOI 10.1182/blood.v106.11.4517.4517 Source: ORCID

  30. Allogeneic haematopoietic cell transplantation in acute myeloblastic laeukemia:: Ibni Sina experience (1989-2004)

    Bone Marrow Transplantation, 2005

    Source: ORCID

  31. BCR,ABL fusion binding HLA molecule frequencies among patients with civil

    Genes and Immunity, 2005

    Source: ORCID

  32. Dose cytosine arabinoside (HD-AraC) vs standard dose AraC (SD-AraC) during induction, and stem cell transplantation followed by IL-2 or no maintenance in acute myelogenous leukemia (AML): First report on the AML-12 phase III trial of the EORTC-leukemia group (LG) and GIMEMA

    Blood, 2005

    Source: ORCID

  33. Expression of IFITM1 in chronic myeloid leukemia patients

    Leukemia Research, 2005

    DOI 10.1016/j.leukres.2004.07.007 PMID 15661263 30 citations (Europe PMC) Open-access full textSource: ORCID

  34. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-Year results from the EBMT randomized trial

    Haematologica, 2005

    Source: ORCID

  35. Imatinib only for molecular relapse is not sufficient to achieve a durable complete chimeric status and molecular remission after allo HCT in CML

    Biology of Blood and Marrow Transplantation, 2005

    DOI 10.1016/j.bbmt.2004.12.072 1 citation (OpenAlex) Open-access full textSource: ORCID

  36. Interleukin-10(IL-10)1082-A and tumor necrosis factor(TNF)alpha 238/308A genotypes are associated with earlier (younger than 55) onset of multiple myeloma

    Genes and Immunity, 2005

    Source: ORCID

  37. Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/ macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: Final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group

    Leukemia, 2005

    DOI 10.1038/sj.leu.2403934 PMID 16151466 22 citations (Europe PMC) Source: ORCID

  38. Marrow plasma cell immunohistochemical expression profiles of cyclins (A, D1, D2, D3), cyclin dependent kinase inhibitors (p16, p21) and Ki67: Predictors of survival in patients with multiple myeloma

    Blood, 2005

    DOI 10.1182/blood.v106.11.5117.5117 Source: ORCID

  39. Multiple myeloma (MM) in young patients (pts):: Clinical features and outcome in 259 patients younger than 40 years in comparison to 8,296 pts aged ≥40 years

    Blood, 2005

    Source: ORCID

  40. The effect of tissue injury on donor-derived hepatocyte repopulation following sex-mismatched hematopoietic stem cell transplantation

    Journal of Hepatology, 2005

    Source: ORCID

  41. The effects of transplantation-related factors and tissue injury on donor-derived cells repopulation following sex-mismatched haematopoietic cell transplantation

    Bone Marrow Transplantation, 2005

    Source: ORCID

  42. The impact of methylenetetrahydrofolate reductase C677T gene polymorphism on engraftment after allogeneic hematopoetic cell transplantation

    Blood, 2005

    DOI 10.1182/blood.v106.11.5318.5318 Source: ORCID

  43. Treatment with arsenic trioxide, ascorbic acid and dexamethasone in advanced myeloma patients: Preliminary findings of a multicenter, phase II study

    Blood, 2005

    DOI 10.1182/blood.v106.11.5135.5135 8 citations (OpenAlex) Source: ORCID

  44. Tumor necrosis factor(TNF)-alpha 238A genotype is associated with an earlier onset of multiple myeloma and better response to thalidomide

    Genes and Immunity, 2005

    Source: ORCID

  45. High Dose Cytosine Arabinoside (HD-AraC) vs Standard Dose AraC (SD-AraC) during Induction, and Stem Cell Transplantation Followed by IL-2 or No Maintenance in Acute Myelogenous Leukemia (AML): First Report on the AML-12 Phase III Trial of the EORTC-Leukemia Group (LG) and GIMEMA.

    Blood, 2005

    DOI 10.1182/blood.v106.11.271.271 3 citations (OpenAlex) Source: OpenAlex

  46. Hematopoetik kök hücre transplant alıcı-verici çiftlerinde öldürücü immünoglobulin-benzer baskılayıcı reseptör (killer inhibitory receptor[KIR]) tiplerinin saptanması

    2005

    Source: OpenAlex

  47. A comparison of the number of informative short tandem repeat (STR) loci between HLA identical donor-recipient pairs and the frequency of graft versus host disease (GVHD)

    Genes and Immunity, 2004

    Source: ORCID

  48. A comparison of the number of informative short tandem repeat loci between HLA identical donor-recipient pairs and the frequency of graft-versus-host disease

    Bone Marrow Transplantation, 2004

    Source: ORCID

  49. Allogeneic hemapoietic progenitor cell collection using four different cell separators:: A retrospective comparative analysis

    Blood, 2004

    Source: ORCID

  50. Apoptosis in the haematopoietic stem cell products obtained by continuous flow apheresis method in allogeneic peripheral stem cell transplantation

    Bone Marrow Transplantation, 2004

    Source: ORCID